Real-time Eye Tracking and Imaging of the Eye in Diabetic Retinopathy Patients

Overseen By Study Coordinator

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: PulseMedica

Disqualifiers: Age, No diabetic retinopathy, Opacification

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 1

60 Participants Needed

Trial Summary

What is the purpose of this trial?

This trial is testing a new camera called the OSNAT800 IO that takes 3D pictures of the back of the eye and tracks eye movements in real-time. It aims to help doctors monitor patients with diabetic retinopathy, a common cause of vision loss. The goal is to see if this device can accurately track eye movements while taking detailed images.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications.

Eligibility Criteria

Inclusion Criteria

Between 18 and 70 years of age

Male or female

Diagnosed diabetic retinopathy

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Retinal Imaging

Participants undergo retinal imaging using the OSNAT800 IO device to assess real-time eye tracking capabilities

Single session

1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after imaging

6 months

Treatment Details

Interventions

• OSNAT 800 IO

Participant Groups

Group I: Retinal Imaging using the OSNAT800 IO device Experimental Treatment 1 Intervention

Patients will have their eyes imaged with the OSNAT800 IO device in addition to a routine standard of care appointment.

Who Is Running the Clinical Trial?

PulseMedica

Lead Sponsor

Trials

3

Recruited

340+